Senti Biosciences Holdings, Inc. Share Price

Senti Biosciences Holdings, Inc. Share Price

NASDAQ: SNTI | Micro Cap
$0.22
+$0.01 (3.91%) Last updated on 29 Oct, 2026 | 23:54 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Senti Biosciences Holdings, Inc. Stock Performance

Open
$0.21
Prev. Close
$0.22
Circuit Range
N/A
Day Range
$0.21 - $0.24
Year Range
$0.16 - $2.86
Volume
9,689
Average Traded
$0.23

Senti Biosciences Holdings, Inc. Share Price Today

As of 30 October 2026, Senti Biosciences Holdings, Inc.'s share price is $0.22. The stock opened at $0.21, compared to its previous close of $0.22. During today's trading session, Senti Biosciences Holdings, Inc.'s share price traded between $0.21 and $0.24, with an average price of $0.22. Over the past 52 weeks, the stock has recorded a high of $2.86 and a low of $0.16. In terms of performance, Senti Biosciences Holdings, Inc.'s share price has declined by 75.44% over the last six months and is down 88.88% on a year-on-year basis.

Senti Biosciences Holdings, Inc. Share Price Chart

Line chart of the Senti Biosciences Holdings, Inc. price trend over the selected period. The price rose overall, ranging from 0.21 to 0.23, ending at 0.22.
$0.21$0.24
L
Show Current Price
H

Senti Biosciences Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.03M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.29
Revenue (TTM)
$20.00M
Return On Equity (TTM)
1457.34%
Profit Margin
-307200.00%
Debt to Equity
-1.17
Quarterly Earnings Growth YoY
29.67%

Senti Biosciences Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.02$0.02$0.02
Net Profit-$18.13-$14.47-$4.22-$12.75
Net Profit MarginN/A-72350.00%-21100.00%-63750.00%
Income ChangeN/A20.19%70.84%-202.13%

Senti Biosciences Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$4.29$2.56$0.00$0.02
Net Profit-$58.21-$71.06-$55.31-$61.44
Net Profit Margin-1356.88%-2775.78%N/A-307200.00%
Income ChangeN/A-22.08%22.16%-11.08%

About Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings Inc, formerly known as Senti Biosciences Inc, is a clinical-stage biotechnology company developing cell and gene therapies using its gene circuit platform for patients with incurable diseases. Its gene circuits, created from proprietary DNA sequences, are designed to reprogram cells to sense, compute, and respond to cellular environments. Its product candidates are to kill cancer cells, spare healthy cells, increase specificity, and control drug expression. Its candidate, SENTI-202, is a logic-gated off-the-shelf CAR-NK cell therapy for blood cancers, currently in a Phase 1 clinical trial in the United States and Australia for relapsed or refractory hematological malignancies, including Acute Myeloid Leukemia (AML).

Senti Biosciences Holdings, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.31
$0.22
-28.98%
Sep 2026
$0.36
$0.31
-20.51%
Aug 2026
$0.38
$0.40
+15.50%
Jul 2026
$1.09
$0.34
-68.48%
Jun 2026
$0.99
$1.08
+14.81%
May 2026
$0.98
$0.94
+3.85%
Apr 2026
$0.85
$0.91
+12.07%
Mar 2026
$0.91
$0.81
-14.44%
Feb 2026
$0.99
$0.95
-5.48%
Jan 2026
$1.06
$1.00
-5.28%
Dec 2025
$2.10
$1.06
-52.47%
Nov 2025
$2.00
$2.23
+11.00%

SNTI Share Price FAQs